Carboplatin Injection Shortage
Last Updated: September 16, 2025
Status: Current
Unavailable, Current:
- Carboplatin, Injection, 10 mg/1 mL (Accord Healthcare Inc.)
- Carboplatin, Injection, 10 mg/1 mL (Teva Pharmaceuticals USA, Inc.)
- Carboplatin, Injection, 450 mg/45 mL (Eugia US LLC)
- Carboplatin, Injection, 450 mg/45 mL (Ingenus Pharmaceuticals LLC)
- Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
- Carboplatin, Injection, 50mg/5mL (Gland Pharma Limited)
- Carboplatin, Injection, 600 mg/60 mL (Ingenus Pharmaceuticals LLC)
Limited Availability, Current:
- Carboplatin, Injection, 10 mg/1 mL (Accord Healthcare Inc.)
- Carboplatin, Injection, 10 mg/1 mL (Teva Pharmaceuticals USA, Inc.)
- Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
- Carboplatin, Injection, 150mg/15mL (Gland Pharma Limited)
- Carboplatin, Injection, 450mg/45mL (Gland Pharma Limited)
- Carboplatin, Injection, 600 mg/65 mL (Gland Pharma Limited)
Available, Current:
- Carboplatin, Injection, 10 mg/1 mL (Accord Healthcare Inc.)
- Carboplatin, Injection, 10 mg/1 mL (Fresenius Kabi USA, LLC)
- Carboplatin, Injection, 10 mg/1 mL (Teva Pharmaceuticals USA, Inc.)
- Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
- Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
- Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
- Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
- Carboplatin, Injection, 600 mg/60 mL (Eugia US LLC)
- Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
- Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
To Be Discontinued:
Carboplatin, Injection, 10 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-295-33Availability: Unavailable
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Requirements related to complying with good manufacturing practices
Related Information: SKU status from FDA is non-Exempt
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 866-941-7875, option 2
Carboplatin, Injection, 10 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-295-31Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 866-941-7875, option 2
Carboplatin, Injection, 10 mg/1 mL (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0703-4248-01Availability: Unavailable
Status: Current
Date of update: September 4, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Estimated recovery: September 2025
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 800-545-8800
Carboplatin, Injection, 450 mg/45 mL (Ingenus Pharmaceuticals LLC)
NDC Code: 50742-447-45Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: For any other information, please contact the Ingenus Customer Service team at 866-321-5031.
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 866-321-5031
Carboplatin, Injection, 450 mg/45 mL (Eugia US LLC)
NDC Code: 55150-335-01Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: On backorder. Recovery: TBD. Check wholesalers for inventory
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 888-238-7880
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
NDC Code: 60505-6282-1Availability: Unavailable
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Discontinuation of the manufacture of the drug.
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Apotex Inc.: 800-706-5575
Related info link: https://dps.fda.gov/drugshortages/discontinuations/carboplatin-injection
Carboplatin, Injection, 50mg/5mL (Gland Pharma Limited)
NDC Code: 54288-164-01Availability: Unavailable
Status: Current
Date of update: July 28, 2025
Update type: Revised
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Discontinued; Distributed by BPI Labs, LLC
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
Carboplatin, Injection, 600 mg/60 mL (Ingenus Pharmaceuticals LLC)
NDC Code: 50742-448-60Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: For any other information, please contact the Ingenus Customer Service team at 866-321-5031.
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 866-321-5031
Carboplatin, Injection, 10 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-295-34Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Requirements related to complying with good manufacturing practices
Related Information: Estimated recovery: TBD
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 866-941-7875, option 2
Carboplatin, Injection, 10 mg/1 mL (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0703-4239-01Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Availability
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 800-545-8800
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
NDC Code: 60505-6282-3Availability: Limited Availability
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Discontinuation of the manufacture of the drug.
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Apotex Inc.: 800-706-5575
Related info link: https://dps.fda.gov/drugshortages/discontinuations/carboplatin-injection
Carboplatin, Injection, 150mg/15mL (Gland Pharma Limited)
NDC Code: 54288-165-01Availability: Limited Availability
Status: Current
Date of update: July 28, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Estimated recovery: Q4 2025; Distributed by BPI Labs, LLC
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
Carboplatin, Injection, 450mg/45mL (Gland Pharma Limited)
NDC Code: 54288-166-01Availability: Limited Availability
Status: Current
Date of update: July 28, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Estimated recovery: Q4 2025; Distributed by BPI Labs, LLC
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
Carboplatin, Injection, 600 mg/65 mL (Gland Pharma Limited)
NDC Code: 54288-167-01Availability: Limited Availability
Status: Current
Date of update: July 28, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Estimated recovery: Q4 2025; Distributed by BPI Labs, LLC
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
Carboplatin, Injection, 10 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-295-12Availability: Available
Status: Current
Date of update: September 5, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 866-941-7875, option 2
Carboplatin, Injection, 10 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-172-60Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 888-386-1300
Carboplatin, Injection, 10 mg/1 mL (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0703-4244-01Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Revised
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 800-545-8800
Carboplatin, Injection, 10 mg/1 mL (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0703-4246-01Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Revised
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 800-545-8800
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-339-22Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-150-05Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-339-50Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-262-05Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
NDC Code: 60505-6282-6Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Related Information: Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Apotex Inc.: 800-706-5575
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-339-18Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-360-18Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 600 mg/60 mL (Eugia US LLC)
NDC Code: 55150-386-01Availability: Available
Status: Current
Date of update: September 5, 2025
Update type: Revised
Related Information: Check wholesalers for inventory
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 888-238-7880
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-339-56Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 61703-600-05Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: 844-646-4398
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (Teyro Labs)
NDC Code: 60505-6282-7Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Related Information: Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Therapeutic category: Oncology
Initial posting date: April 28, 2023
Contact info: Apotex Inc.: 800-706-5575
Carboplatin, Injection, 10 mg/1 mL (Teyro Labs)
NDC Code: 60505-6282-3Status: To Be Discontinued
Date of update: March 28, 2025
Update type: New
Related Information: Discontinuation due to low sales volume. Supply currently available with November 2025 expiry dating. Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Therapeutic category: Oncology
Date discontinued: March 28, 2025
Initial posting date: March 28, 2025
Contact info: 800-706-5575
Carboplatin, Injection, 10 mg/1 mL (Teyro Labs)
NDC Code: 60505-6282-1Status: To Be Discontinued
Date of update: March 28, 2025
Update type: New
Related Information: Discontinuation due to low sales volume. Supply currently available with June 2025 expiry dating. Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Therapeutic category: Oncology
Date discontinued: March 28, 2025
Initial posting date: March 28, 2025
Contact info: 800-706-5575
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.